Investigación

Genómica Traslacional

Buscador de publicaciones

Publicaciones

  • Achatz MI, Porter CC, Brugières L, Druker H, Frebourg T, Foulkes WD, Kratz CP, Kuiper RP, Hansford JR, Salvador-Hernandez H, Nathanson KL, Kohlmann WK, Doros L, Onel K, Schneider KW, Scollon SR, Tabori U, Tomlinson GE, Evans DGR and Plon SE.

    Cancer Screening Recommendations and Clinical Management of Inherited Gastrointestinal Cancer Syndromes in Childhood.

    CLINICAL CANCER RESEARCH . 23(13): 107-114. Nº de citas: 84

    [doi:10.1158/1078-0432.CCR-17-0790]

  • Evans DGR, Salvador-Hernandez H, Chang VY, Erez A, Voss SD, Druker H, Scott HS and Tabori U.

    Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders.

    CLINICAL CANCER RESEARCH . 23(12): 54-61. Nº de citas: 64

    [doi:10.1158/1078-0432.CCR-17-0590]

  • Evans DGR, Salvador-Hernandez H, Chang VY, Erez A, Voss SD, Schneider KW, Scott HS, Plon SE and Tabori U.

    Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1.

    CLINICAL CANCER RESEARCH . 23(12): 46-53. Nº de citas: 112

    [doi:10.1158/1078-0432.CCR-17-0589]

  • Masvidal L, Iniesta R, Garcia-López M, Casalà C, Lavarino C, Mora J and de Torres C.

    Genetic Variants in the Promoter Region of the Calcium-Sensing Receptor Gene Are Associated With Its Down-Regulation in Neuroblastic Tumors

    MOLECULAR CARCINOGENESIS . 56(4): 1281-1289. Nº de citas: 14

    [doi:10.1002/mc.22589]

  • Mohammad F, Weissmann S, Leblanc B, Pandey DP, Højfeldt JW, Comet I, Zheng C, Johansen JV, Rapin N, Porse BT, Tvardovskiy A, Jensen ON, Gene-Olaciregui N, Lavarino C, Suñol M, de Torres C, Mora J, Carcaboso AM and Helin K.

    EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas

    NATURE MEDICINE . 23(4): 483-492. Nº de citas: 416

    [doi:10.1038/nm.4293]

  • Monterrubio C, Paco-Mercader S, Gene-Olaciregui N, Pascual-Pastó G, Vilà-Ubach M, Cuadrado-Vilanova M, Ferrandiz MM, Castillo-Ecija H, Glisoni R, Kuplennik N, Jungbluth A, de Torres C, Lavarino C, Cheung NV, Mora J, Sosnik A and Carcaboso AM.

    Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8

    JOURNAL OF CONTROLLED RELEASE . 255: 108-119. Nº de citas: 36

    [doi:10.1016/j.jconrel.2017.04.016]

  • Salas S, Agut-Quijano T, Rovira-Zurriaga C, Canizo D, Lavarino C and García-Alix A.

    Infratentorial congenital glioblastoma multiforme. A rare tumour with a still unknown biology

    REVISTA DE NEUROLOGIA . 63(9): 411-414. Nº de citas: 2

    [doi:10.33588/rn.6309.2016208]

  • Pascual-Pastó G, Gene-Olaciregui N, Vilà-Ubach M, Paco-Mercader S, Monterrubio C, Rodriguez E, Winter U, Batalla-Vilacís M, Català-Mora J, Salvador-Hernandez H, Parareda A, Schaiquevich P, Suñol M, Mora J, Lavarino C, de Torres C, Chantada G and Carcaboso AM.

    Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination

    CANCER LETTERS . 380(1): 10-19. Nº de citas: 27

    [doi:10.1016/j.canlet.2016.06.012]

  • Hernandez-Muñoz I, Figuerola-Bou E, Sánchez-Molina S, Rodriguez E, Fernández-Mariño AI, Pardo-Pastor C, Bahamonde MI, Fernández-Fernández JM, García-Domínguez DJ, Hontecillas-Prieto L, Lavarino C, Carcaboso AM, de Torres C, Tirado OM, de Alava E and Mora J.

    RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-?B pathway, independently of the fusion oncoprotein

    Oncotarget . 7(29): 46283-46300. Nº de citas: 12

    [doi:10.18632/oncotarget.10092]

  • Rodriguez-Hernandez CJ, Mateo-Lozano S, Garcia-López M, Casalà C, Briansó F, Castrejon N, Rodriguez E, Suñol M, Carcaboso AM, Lavarino C, Mora J and de Torres C.

    Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens

    Oncotarget . 7(13): 16112-16129. Nº de citas: 17

    [doi:10.18632/oncotarget.7448]